Development) million baht 7,378 6,976 7,319 Operating expenses (include Research and Development) to sales (%) 13.90% 14.17% 15.61% profit marginOperating (%) 8.94% 11.32% 10.87% Other income to total revenues
Research and Development) million baht 8,180 7,378 6,976 Operating expenses (including Research and Development) to sales (%) 16.00% 13.90% 14.17% Operating profit margin (%) 4.48% 8.94% 11.32% Other income
income ection and ot ntal and serv al revenues st of Sales st of Services st of rental an ss Profit Discussion and c Company Lim 015 Manag Presid The St g to Jaymar 9 Novemb any and th s already be pany’s
Development) million baht 6,976 7,319 6,599 Operating expenses to sales (%) 14.16% 15.61% 14.06% Operating profit margin (%) 11.31% 10.87% 13.23% Other income to total revenues (%) 2.22% 1.60% 2.20% Net profit
. Income from medical treatments in the consolidated financial Statement went up 6.81% due to income from Chiang Mai Ram Medical Business Plc.”CMR”, a subsidiary amount Baht 3,747.64 million went up from
ended 31 March 2021 which was reviewed by the auditor. The Company’s overall performance can be summarized as follows: Performance (Statement of comprehensive income) 1Q2021 1Q2020 Increase/ (Decrease
integration and quality of earnings. The Company has in motion several earnings-accretive capital investment brownfield projects and de-bottlenecks which are budgeted to have higher returns than our entire
integration and quality of earnings. The Company has in motion several earnings-accretive capital investment brownfield projects and de-bottlenecks which are budgeted to have higher returns than our entire
which was audited by the auditor. The Company’s overall performance can be summarized as follows: Performance Unit: THB Million 2022 2023 Inc.(Dec.) % Inc.(Dec.) Services income 331.18 317.89 (13.29
results of WIIK and its subsidiaries for the three-month period ended September 30, 2019 as follows. Summarized of the Statement of income Unit : million Baht Quarter 3/2019 Quarter 3/2018 Changed